Depending on glycemic control, the total daily dose may be reduced by 10–20% or more in case of frequent hypoglycemia or high total insulin dose during MDI, then using 30–50% of total daily dose as daily basal rate [12, 13]. This evidence concerns the gene INS and Hypoglycemia.